Evidence suggests that SIRT1 activation may be dependent on PI3K/AKT signaling while SIRT2 inhibitors AK1 and AGK2 have demonstrated the capacity to attenuate the p-AKT/Foxo3a signaling axis in ischemic stroke models (Duan et al., 2019). The gene discussed is FOXO3; the disease is ischemic stroke.